Protecting Kidney Function: Early CKD Study
Starting soon: a study of an investigational treatment to slow early-stage chronic kidney disease.
Chronic kidney disease often progresses silently. This upcoming study will evaluate whether an investigational treatment can slow the decline of kidney function in adults with early-stage CKD. Register your interest now and the research team will contact you when enrolment opens.
What participants receive
- Comprehensive kidney function testing
- Nephrologist-supervised study care
- Study medication at no cost once enrolled
Could this study be for you?
You may qualify if you…
- Are 18–79 years of age
- Have been told you have reduced kidney function (stage 2–3 CKD)
- Have blood pressure under reasonable control
You may not qualify if you…
- Are on dialysis
- Have received a kidney transplant
These lists are highlights only. Only the study doctor can finally determine whether you are eligible to participate.
Participating locations
Lakeshore Clinical Research — Toronto
Dr. Priya Raman, MD, FRCPC · Toronto
View clinic
Join this study
Share your contact details and a research professional will call you to talk through the study and assess your eligibility. There is no obligation, and you may withdraw at any time.